Snowball logo
logo
DGNS

Diagnos Laboratorium Utama PT Tbk

DGNS • JK
Rp296.00-Rp2.00  (0.67%)
Estimate
P/E
5.7
EPS
51.842
Beta
0.382
Growth
Revenue, YoY
13.67%
Net income, YoY
-322.89%
FCF, YoY
-130.6%
About the company
Ticker
DGNS
ISIN
ID1000158702
Country
Indonesia
Sector (GICS)
Healthcare
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia, and other bacteria; genomics; homecare services; and inspection panel tests. It also provides clinical pathology, anatomical pathology, and microbiology laboratory; and corporate health and research services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Frequently asked questions

What sector does Diagnos Laboratorium Utama PT Tbk (DGNS) operate in?

Diagnos Laboratorium Utama PT Tbk belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Diagnos Laboratorium Utama PT Tbk (DGNS) current stock price?

As of the latest data, Diagnos Laboratorium Utama PT Tbk stock price is IDR 296, with a previous close of IDR 298. Diagnos Laboratorium Utama PT Tbk lost -IDR 2 in the last trading session, representing a -0.67% loss.

What is Diagnos Laboratorium Utama PT Tbk (DGNS) current market capitalization?

Diagnos Laboratorium Utama PT Tbk market cap is approximately 407.00 billion.

What is Diagnos Laboratorium Utama PT Tbk (DGNS) Earnings Per Share (EPS)?

The trailing EPS is IDR 52.

What is Diagnos Laboratorium Utama PT Tbk (DGNS) Price-to-Earnings (P/E) ratio?

Diagnos Laboratorium Utama PT Tbk current P/E ratio is 5.71.

What is Diagnos Laboratorium Utama PT Tbk (DGNS) EBITDA?

Diagnos Laboratorium Utama PT Tbk EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.67 billion.

Does Diagnos Laboratorium Utama PT Tbk (DGNS) pay dividends?

No. Diagnos Laboratorium Utama PT Tbk does not pay a dividend.

What is Diagnos Laboratorium Utama PT Tbk (DGNS) beta (volatility) score?

Diagnos Laboratorium Utama PT Tbk has a beta of 0.382, indicating lower volatility than the overall market.